Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003901 · ClinicalTrials.gov registry record · Phase 3
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,310
- Enrollment target
NCT00003901 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,310 participants.
The verdict
NCT00003901, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,310 participants
- Enrollment target
Study Summary
RATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment. PURPOSE: Phase III trial to study the relationship between early signs of metastases and survival in patients who have stage I, stage II, or stage III non-small cell lung cancer that can be removed by surgery.
Interventions
- PROCEDURE biopsy
- OTHER immunohistochemistry staining method
- PROCEDURE surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,310 participants |
| Start Date | 1999-07 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003901
The ClinicalTrials.gov registry entry for NCT00003901 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which biopsy is the first listed.
NCT00003901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003901 about?
NCT00003901 is a clinical study titled "Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery". RATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment. PURPOSE: Phase III trial to study the relationship between early signs of metastases and survival in patients who have stage I, stage II, or stage III non-small ce...
What is the current status of trial NCT00003901?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,310 participants. The study started on 1999-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00003901?
The interventions under investigation include: biopsy (PROCEDURE), immunohistochemistry staining method (OTHER), surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00003901?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.